2/9 2023

Vivacelle Bio’s VBI-S Phase IIa clinical trial meets primary and secondary endpoints for treating hypovolemia in septic shock patients

2023-05-18T08:27:47-04:00February 9th, 2023|ATI in the News|

Vivacelle Bio, Inc., a privately held life science company focused on the development of treatments for hypovolemia in shock including septic shock and hemorrhagic shock, announced the successful completion of its Phase IIa clinical trial of VBI-S in septic shock patients with severe hypovolemia.

8/11 2022

Medical Innovation Challenge announces contenders for $200,000 award

2023-05-18T08:25:34-04:00August 11th, 2022|Press Releases|

Advanced Technology International (ATI) and TechConnect today announced 25 finalists who will pitch on September 28, 2022 at Defense TechConnect Innovation Summit for $200,000 in non-dilutive awards. These candidates receive membership from four consortia with a combined $50B in federal contracting authority including: Medical CBRN Defense Consortium (MCDC), Countering Weapons of Mass Destruction Consortium (CWMD), Medical Technology Enterprise Consortium (MTEC), and Senior Healthcare Innovation Consortium (SHIC).

6/21 2022

Army asks industry to develop handheld sensor to help care for military burn victims on the front lines

2023-05-18T08:25:49-04:00June 21st, 2022|ATI in the News|

This handheld device is for Army battalion aid stations, brigade support aid stations,and field hospitals for triaging and evacuation decision making. Officials of the Medical Technology Enterprise Consortium (MTEC) in Summerville, S.C., issued a request for project proposals (MTEC-22-08-BDA) on Friday for the Burn Digital Assessment project.

6/7 2022

NuCressTM bone scaffolding solution for healing bone trauma on the battlefield and beyond

2023-05-18T08:25:49-04:00June 7th, 2022|ATI in the News|

These efforts have been successful, and Dr. Biris’ university spinout venture NuShores received a fourth award in FY20 by the U.S. Army’s Medical Research and Development Command’s Clinical and Rehabilitative Research Program (CRMRP) via an Other Transaction Agreement (OTA) competitively awarded through the Medical Technology Enterprise Consortium (MTEC). This transition of the initial NuCressTM manufacturing process from the JWMRP to the MTEC focuses on the optimization of the manufacturing process by investigating multiple and consecutive iterations of automation to improve quality, cost and efficiency. The deliverable is to demonstrate the feasibility of producing the NuCressTM bone void filler scaffold by a fully automated, intelligent production system with real-time in-process quality monitoring and control.

5/31 2022

MIMEDX receives $4.6 million award from the Department of Defense to advance the treatment of combat casualty wounds and burns

2023-05-18T08:25:50-04:00May 31st, 2022|ATI in the News|

The award from the Medical Technology Enterprise Consortium (MTEC), a 501(c)(3) biomedical technology consortium collaborating under an Other Transaction Agreement (OTA) with the U.S. Army Medical Research and Development Command, is sponsored and will be managed by the Naval Medical Research Center (NMRC) to advance medical treatments for combat wounds and burns.

5/26 2022

NMRC presented with MTEC 2022 sponsor recognition award

2023-05-18T08:25:50-04:00May 26th, 2022|ATI in the News|

“Through MTEC, NMRC is harnessing the innovation of academia and the biotechnology sector to develop and eventually deliver technology to the warfighter,” said Thomas Dunn, acting program manager of NMRC’s Naval Advanced Medical Development department. “MTEC helps survey the scope of innovative research, and to see how that research can be used to meet the needs of military medicine.”

5/9 2022

The magic glove

2023-05-18T08:25:51-04:00May 9th, 2022|ATI in the News|

How exactly the ReHeal Glove got to where it is now—flush with funding and undergoing various rounds of testing—is largely due to the role of the Medical Technology Enterprise Consortium (MTEC), a nonprofit corporation that operates as the premier facilitator and collaborator across the entire DOD. Indeed, if it weren’t for MTEC, the near decade-long effort to develop the ReHeal Glove may have withered on the vine. Instead, it provides a promising medical option for millions.

Go to Top